(Q34388959)

English

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Atrial Fibrillation

0 references

0 references

(E)-phytonadione

1 reference

based on heuristic

inferred from title

Scott D Berkowitz

object named as

Scott D Berkowitz

7

0 references

Graeme J. Hankey

object named as

Graeme J Hankey

15

0 references

18

object named as

Robert M Califf

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Kenneth W Mahaffey

8

object named as

Kenneth W Mahaffey

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jonathan P. Piccini

3

object named as

Jonathan P Piccini

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jonathan L. Halperin

12

object named as

Jonathan L Halperin

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Günter Breithardt

16

object named as

Gunter Breithardt

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Daniel E. Singer

14

object named as

Daniel E Singer

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

object named as

Daniel M Wojdyla

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Matthew W Sherwood

10

object named as

Matthew W Sherwood

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

object named as

Harvey D White

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Christopher C Nessel

6

object named as

Christopher C Nessel

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Shaun G Goodman

1

object named as

Shaun G Goodman

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

John F Paolini

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Manesh R Patel

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Richard C Becker

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Werner Hacke

13

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Keith A A Fox

17

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ROCKET AF Investigators

19

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

4 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

891-900

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

New oral anticoagulants: a view from the laboratory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

6 July 2018

Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

27 October 2018

Stroke prevention versus bleeding risk in atrial fibrillation: a clinical dilemma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

27 October 2018

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

27 October 2018

Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

27 October 2018

Bleeding risk assessment and management in atrial fibrillation patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

9 December 2018

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206565

9 December 2018

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24315894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/24315894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24315894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with

1 reference

https://pubmed.ncbi.nlm.nih.gov/24315894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24315894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JACC.2013.11.013

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34388959&oldid=2118254793"